Eupraxia Pharmaceuticals ...
3.08
0.03 (0.98%)
At close: Jan 15, 2025, 3:58 PM
3.16
2.60%
After-hours Jan 15, 2025, 04:00 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Net Income -37.39M -23.92M -23.37M -4.01M -7.24M -14.83M -5.00M
Depreciation & Amortization 209.91K 193.27K 111.53K 116.81K 201.94K 125.83K 85.38K
Stock-Based Compensation 1.41M 1.43M 4.21M 228.68K 544.95K 2.92M 162.82K
Other Working Capital 6.47M 1.76M -402.32K 832.37K 346.87K 1.31M -259.17K
Other Non-Cash Items 1.53M 1.16M 3.41M 1.69M 869.41K 2.08M 51.17K
Deferred Income Tax n/a -305.15K 1.20M 10.91K -28.86K 291.05K n/a
Change in Working Capital 6.33M 2.07M -211.43K 1.56M 482.14K 1.10M -599.39K
Operating Cash Flow -27.92M -18.78M -14.64M -403.93K -5.17M -8.32M -5.30M
Capital Expenditures -73.38K -308.37K -431.67K n/a -9.48K -141.86K -314.69K
Acquisitions n/a 310.00 n/a 81.31K n/a n/a n/a
Purchase of Investments n/a -310 -9.00M n/a n/a n/a n/a
Sales Maturities Of Investments n/a 9.01M n/a n/a n/a n/a n/a
Other Investing Acitivies -1.81K 310.00 -5.02M -56.69K -1.89M n/a n/a
Investing Cash Flow -99.03K 8.70M -14.45M 24.62K -1.90M -141.86K -314.69K
Debt Repayment -144.44K -97.49K 12.17M -525.95K 5.66M 2.67M 463.06K
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 12.10M 2.98M 8.07M -100.69K 1.73M 2.62M 1.81M
Financial Cash Flow 27.84M 13.52M 49.92M -626.64K 7.40M 5.30M 9.47M
Net Cash Flow 1.08M 3.84M 20.74M -1.01M 332.60K -3.17M 3.85M
Free Cash Flow -28.02M -19.08M -15.07M -403.93K -5.18M -8.46M -5.61M